Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-7,249
Closed -$957K 121
2024
Q1
$957K Buy
7,249
+376
+5% +$46.3K 0.58% 49
2023
Q4
$749K Sell
6,873
-191
-3% -$19.8K 0.52% 47
2023
Q3
$727K Sell
7,064
-881
-11% -$95K 0.63% 44
2023
Q2
$917K Buy
7,945
+580
+8% +$65.9K 0.68% 41
2023
Q1
$784K Sell
7,365
-615
-8% -$66.4K 0.67% 39
2022
Q4
$885K Buy
+7,980
New +$816K 0.77% 38

Other funds holding MRK

AlphaQ Advisors's MRK Position: Q2 2024 in Review

AlphaQ Advisors sold out of Merck (MRK) in Q2 2024, closing a stake of 7,249 shares — an estimated $957K sold.

AlphaQ Advisors first reported a position in MRK in Q4 2022 and held it in 6 quarters. The position peaked at $957K in Q1 2024. 3,545 funds tracked by Wall St. Rank hold MRK as of Q2 2024.

  • AlphaQ Advisors reported no remaining Merck position as of Q2 2024 after selling out during the quarter.
  • AlphaQ Advisors sold 7,249 Merck shares in Q2 2024, an estimated $957K.
  • AlphaQ Advisors first reported a position in Merck in Q4 2022 and held it in 6 quarters.
  • AlphaQ Advisors's Merck position peaked at $957K in Q1 2024.
  • 3,545 funds tracked by Wall St. Rank held Merck as of Q2 2024.

Based on AlphaQ Advisors's 13F filing for Q2 2024, filed 26 Jul 2024.